{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T07:14:04Z","timestamp":1793258044994,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T00:00:00Z","timestamp":1666656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T00:00:00Z","timestamp":1666656000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Metabolism-related indicators have been suggested as possible prognostic indicators of liver disease in recent relevant studies, but their value in predicting autoimmune hepatitis (AIH) cirrhosis is unclear. This study evaluated the role of lipid levels in determining the prognosis of AIH-related cirrhosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We retrospectively included 345 patients with AIH who were initially diagnosed at Beijing Ditan Hospital from 2010-2019, and ultimately screened 196 patients who met the criteria. A logistic regression analysis was performed to screen factors associated with cirrhosis. Kaplan\u2013Meier (KM) curves were constructed to analyze the effects of different triglyceride (TG) levels on the survival of patients with cirrhosis. A restricted cubic spline fitted Cox regression model was used to analyze the nonlinear relationship between serum TG levels and patient prognosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Patients with AIH cirrhosis have lower TG levels than those without cirrhosis. Lower serum TG levels correlated with the severity of cirrhosis. The survival analysis showed that TG levels were associated with the overall survival of patients with AIH, as a lower 5-year survival rate (log-rank<jats:italic>P<\/jats:italic>&lt;0.05) was observed for patients in the TG\u22640.95 mmol\/L group (hazard ratio (HR)=3.79, 95% CI: 1.528-9.423). In addition, lower TG levels were associated with a higher incidence of death in patients with AIH cirrhosis. The risk of death gradually increased for the interval of TG levels of 0.5-0.8 mmol\/L (<jats:italic>P<\/jats:italic>for nonlinearity&lt;0.001), and the hazard ratio per standard deviation increase in the TG level was 0.97 (95% CI: 0.94-0.99). The plot showed a U-shaped relationship between TG levels and the survival of patients with decompensated cirrhosis. The risk ratio progressively decreased with lower TG levels (<jats:italic>P<\/jats:italic>for nonlinearity=0.002). Below 0.6 mmol\/L, the probability of TG risk per standard deviation prediction was 1.49 (95% CI: 1.00-2.24).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Serum TG levels are closely related to the disease severity and overall survival of patients with AIH cirrhosis and may be used as a new indicator of advanced liver disease and long-term prognosis.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12944-022-01716-9","type":"journal-article","created":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T04:03:10Z","timestamp":1666670590000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Role of triglycerides as a predictor of autoimmune hepatitis with cirrhosis"],"prefix":"10.1186","volume":"21","author":[{"given":"Peng","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunyun","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,25]]},"reference":[{"key":"1716_CR1","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s12072-021-10170-1","volume":"15","author":"G Wang","year":"2021","unstructured":"Wang G, Tanaka A, Zhao H, et al. The Asian Pacific Association for the Study of the Liver clinical practice guidance: the diagnosis and management of patients with autoimmune hepatitis. Hepatol Int. 2021;15:223\u201357.","journal-title":"Hepatol Int"},{"issue":"6","key":"1716_CR2","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1007\/s12072-016-9767-9","volume":"10","author":"A Tanaka","year":"2016","unstructured":"Tanaka A, Ma X, Yokosuka O, et al. Autoimmune liver diseases in the Asia-Pacifc region: proceedings of APASL symposium on AIH and PBC 2016. Hepatol Int. 2016;10(6):909\u201315.","journal-title":"Hepatol Int"},{"key":"1716_CR3","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1007\/s12016-016-8583-2","volume":"52","author":"Z Wang","year":"2017","unstructured":"Wang Z, Sheng L, Yang Y, et al. The Management of Autoimmune Hepatitis Patients with Decompensated Cirrhosis: Real-World Experience and a Comprehensive Review. Clinic Rev Allerg Immunol. 2017;52:424\u201335.","journal-title":"Clinic Rev Allerg Immunol"},{"key":"1716_CR4","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/S1665-2681(19)31493-0","volume":"11","author":"G Landeira","year":"2012","unstructured":"Landeira G, Morise S, Fassio E, et al. Effect of cirrhosis at baseline on the outcome of type 1 autoimmune hepatitis. Ann Hepatol. 2012;11:100\u20136.","journal-title":"Ann Hepatol"},{"key":"1716_CR5","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/hep.20732","volume":"42","author":"JJ Feld","year":"2005","unstructured":"Feld JJ, Dinh H, Arenovich T, et al. Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome. Hepatology. 2005;42:53\u201362.","journal-title":"Hepatology"},{"issue":"4","key":"1716_CR6","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.jhep.2021.12.041","volume":"76","author":"S Pape","year":"2022","unstructured":"Pape S, Snijders RJALM, Gevers TJ, et al. Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group. J Hepatol. 2022;76(4):841\u20139.","journal-title":"J Hepatol"},{"issue":"6","key":"1716_CR7","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1080\/00325481.2021.1930560","volume":"133","author":"R Feng","year":"2021","unstructured":"Feng R, Guo X, Kou Y, et al. Association of lipid profile with decompensation, liver dysfunction, and mortality in patients with liver cirrhosis. Postgrad Med. 2021;133(6):626\u201338.","journal-title":"Postgrad Med"},{"key":"1716_CR8","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1002\/ijc.30818","volume":"141","author":"P Nderitu","year":"2017","unstructured":"Nderitu P, Bosco C, Garmo H, et al. The association between individual metabolic syndrome components, primary liver cancer and cirrhosis: a study in the Swedish AMORIS cohort. Int J Cancer. 2017;141:1148\u201360.","journal-title":"Int J Cancer"},{"issue":"3","key":"1716_CR9","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/S1542-3565(04)00622-6","volume":"3","author":"A Habib","year":"2005","unstructured":"Habib A, Mihas A, Abouassi S, et al. High-density lipoprotein cholesterol as an indicator of liver function and prognosis in noncholestatic cirrhotics. Clin Gastroenterol Hepatol. 2005;3(3):286\u201391.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1716_CR10","first-page":"9927330","volume":"2021","author":"H Xia","year":"2021","unstructured":"Xia H, Xiaoyun L, Songqing P, et al. Association of Low High-Density Lipoprotein Cholesterol Levels with Poor Outcomes in Hepatitis B-Associated Decompensated Cirrhosis Patients. Biomed Res Int. 2021;2021:9927330.","journal-title":"Biomed Res Int"},{"issue":"19","key":"1716_CR11","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1002\/elps.201200629","volume":"34","author":"S Chen","year":"2013","unstructured":"Chen S, Yin P, Zhao X, et al. Serum lipid profiling of patients with chronic hepatitis B, cirrhosis, and hepatocellular carcinoma by ultra fast LC\/IT-TOF MS. Electrophoresis. 2013;34(19):2848\u201356.","journal-title":"Electrophoresis"},{"issue":"1","key":"1716_CR12","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1186\/s12944-018-0898-y","volume":"17","author":"X Liu","year":"2018","unstructured":"Liu X, Li M, Wang X, et al. Effect of serum triglyceride level on the prognosis of patients with hepatocellular carcinoma in the absence of cirrhosis. Lipids Health Dis. 2018;17(1):248.","journal-title":"Lipids Health Dis"},{"issue":"17-18","key":"1716_CR13","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s00508-019-01544-5","volume":"131","author":"LW Unger","year":"2019","unstructured":"Unger LW, Forstner B, Schneglberger S, et al. Patterns and prevalence of dyslipidemia in patients with different etiologies of chronic liver disease. Wiener klinische Wochenschrift. 2019;131(17-18):395\u2013403.","journal-title":"Wiener klinische Wochenschrift"},{"issue":"1","key":"1716_CR14","doi-asserted-by":"publisher","first-page":"64","DOI":"10.5604\/01.3001.0010.7536","volume":"17","author":"S Gitto","year":"2018","unstructured":"Gitto S, Cicero AFG, Loggi E, et al. Worsening of serum lipid profile after direct acting antiviral treatment. Ann Hepatol. 2018;17(1):64\u201375.","journal-title":"Ann Hepatol"},{"issue":"1","key":"1716_CR15","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/hep.22322","volume":"48","author":"EM Hennes","year":"2008","unstructured":"Hennes EM, Zeniya M, Czaja AJ, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology. 2008;48(1):169\u201376.","journal-title":"Hepatology"},{"key":"1716_CR16","doi-asserted-by":"publisher","first-page":"18017","DOI":"10.1038\/nrdp.2018.17","volume":"4","author":"G Mieli-Vergani","year":"2018","unstructured":"Mieli-Vergani G, Vergani D, Czaja AJ, et al. Autoimmune hepatitis. Nat Rev Dis Primers. 2018;4:18017.","journal-title":"Nat Rev Dis Primers"},{"key":"1716_CR17","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1002\/hep.20503","volume":"41","author":"W Dunn","year":"2005","unstructured":"Dunn W, Jamil LH, Brown LS, et al. MELD accurately predicts mortality in patients with alcoholic hepatitis. Hepatology. 2005;41:353\u20138.","journal-title":"Hepatology"},{"issue":"6","key":"1716_CR18","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1016\/j.jhep.2016.07.020","volume":"65","author":"A Marrero Jorge","year":"2016","unstructured":"Marrero Jorge A, Masatoshi K, Venook Alan P, et al. Observational registry of sorafenib use in clinical practice across Child-Pugh subgroups: The GIDEON study. J Hepatol. 2016;65(6):1140\u20137.","journal-title":"J Hepatol"},{"key":"1716_CR19","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.humpath.2018.07.014","volume":"82","author":"A Gurung","year":"2018","unstructured":"Gurung A, Assis DN, McCarty TR, et al. Histologic features of autoimmune hepatitis: a critical appraisal. Hum Pathol. 2018;82:51\u201360.","journal-title":"Hum Pathol"},{"key":"1716_CR20","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/hep.1840010511","volume":"1","author":"RG Knodell","year":"1981","unstructured":"Knodell RG, Ishak KG, Black WC, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology. 1981;1:431\u20135.","journal-title":"Hepatology"},{"key":"1716_CR21","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","volume":"22","author":"K Ishak","year":"1995","unstructured":"Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol. 1995;22:696\u20139.","journal-title":"J Hepatol"},{"issue":"5","key":"1716_CR22","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1111\/liv.15217","volume":"42","author":"AW Lohse","year":"2022","unstructured":"Lohse AW, Sebode M, Bhathal PS, et al. Consensus recommendations for histological criteria of autoimmune hepatitis from the International AIH Pathology Group: Results of a workshop on AIH histology hosted by the European Reference Network on Hepatological Diseases and the European Society of Pathology: Results of a workshop on AIH histology hosted by the European Reference Network on Hepatological Diseases and the European Society of Pathology. Liver Int. 2022;42(5):1058\u201369.","journal-title":"Liver Int"},{"issue":"4","key":"1716_CR23","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S1665-2681(19)31342-0","volume":"12","author":"M Jani\u010dko","year":"2013","unstructured":"Jani\u010dko M, Vesel\u00edny E, Le\u0161ko D, et al. Serum cholesterol is a significant and independent mortality predictor in liver cirrhosis patients. Ann Hepatol. 2013;12(4):581.","journal-title":"Ann Hepatol"},{"issue":"6","key":"1716_CR24","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1080\/00325481.2021.1930560","volume":"133","author":"R Feng","year":"2021","unstructured":"Feng R, Guo X, Kou Y, et al. Association of lipid profile with decompensation, liver dysfunction, and mortality in patients with liver cirrhosis. Postgraduate Medicine. 2021;133(6):626\u201338.","journal-title":"Postgraduate Medicine"},{"issue":"4","key":"1716_CR25","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1194\/jlr.R119000547","volume":"61","author":"S Jeon","year":"2020","unstructured":"Jeon S, Carr R. Alcohol effects on hepatic lipid metabolism. J Lipid Res. 2020;61(4):470\u20139.","journal-title":"J Lipid Res"},{"issue":"8","key":"1716_CR26","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s11894-019-0706-5","volume":"21","author":"LB Palmer","year":"2019","unstructured":"Palmer LB, Kuftinec G, Pearlman M, et al. Nutrition in Cirrhosis. Curr Gastroenterol Rep. 2019;21(8):38.","journal-title":"Curr Gastroenterol Rep"},{"issue":"6","key":"1716_CR27","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1016\/j.jhep.2011.06.004","volume":"55","author":"MF Bassendine","year":"2011","unstructured":"Bassendine MF, Sheridan DA, Felmlee DJ, et al. HCV and the hepatic lipid pathway as a potential treatment target. J Hepatol. 2011;55(6):1428\u201340.","journal-title":"J Hepatol"},{"issue":"3","key":"1716_CR28","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1055\/s-2004-832941","volume":"24","author":"CH Halsted","year":"2004","unstructured":"Halsted CH. Nutrition and alcoholic liver disease. Semin Liver Dis. 2004;24(3):289\u2013304.","journal-title":"Semin Liver Dis"},{"key":"1716_CR29","doi-asserted-by":"crossref","unstructured":"Miyake Y, Iwasaki Y, Terada R, et al. A model for estimating cirrhosis in patients with type 1 autoimmune hepatitis.\u00a0Hepatol Res.\u00a02008;38(7):658\u201363.","DOI":"10.1111\/j.1872-034X.2008.00329.x"},{"issue":"3","key":"1716_CR30","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1002\/hep.21074","volume":"43","author":"AJ Czaja","year":"2006","unstructured":"Czaja AJ, et al. Distinctive clinical phenotype and treatment outcome of type 1 autoimmune hepatitis in the elderly. Hepatology. 2006;43(3):532\u20138.","journal-title":"Hepatology"},{"issue":"4","key":"1716_CR31","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s10238-013-0262-5","volume":"14","author":"L Chrostek","year":"2014","unstructured":"Chrostek L, Supronowicz L, Panasiuk A, et al. The effect of the severity of liver cirrhosis on the level of lipids and lipoproteins. Clin Experimental Med. 2014;14(4):417\u201321.","journal-title":"Clin Experimental Med"},{"issue":"1","key":"1716_CR32","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4103\/1687-4293.132962","volume":"7","author":"KH Morsy","year":"2012","unstructured":"Morsy KH, Ghaliony MAA, Kobeisy MA. Lipid profile among cirrhotic patients with and without hepatocellular carcinoma in upper Egypt. J Arab Soc Med Res. 2012;7(1):33\u20137.","journal-title":"J Arab Soc Med Res"},{"issue":"1","key":"1716_CR33","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1186\/s12876-020-01522-6","volume":"20","author":"R Cheng","year":"2020","unstructured":"Cheng R, Tan N, Kang Q, et al. High-density lipoprotein cholesterol is a predictor of survival in cirrhotic patients with acute gastrointestinal bleeding: a retrospective study. BMC Gastroenterol. 2020;20(1):381.","journal-title":"BMC Gastroenterol"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-022-01716-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-022-01716-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-022-01716-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,6]],"date-time":"2024-10-06T13:22:49Z","timestamp":1728220969000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-022-01716-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,25]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1716"],"URL":"https:\/\/doi.org\/10.1186\/s12944-022-01716-9","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,25]]},"assertion":[{"value":"28 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the ethics committee of Beijing Ditan Hospital, Capital Medical University and the contents are in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication was obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"108"}}